Urology Health - Hormone Sensitive Prostate Cancer (HSPC) with Dr. Daniel Parker

Advertisement

Centro de recursos Patient Magazine Podcast Donate

Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.

Hormone Sensitive Prostate Cancer (HSPC) with Dr. Daniel Parker

Headshot of Dr. Daniel C. Parker.

Our guest is Dr. Daniel Parker, an associate professor at the University of Oklahoma Health Sciences Center, who specializes in urologic oncology. He is here to talk with us about Hormone Sensitive Prostate Cancer and treatment intensification.

Short on time? Use the below timestamps to jump to any topic section:
0:38 - Introduction
1:02 - What is Hormone Sensitive Prostate Cancer (HSPC)?
2:25 - How common is HSPC?
4:01 - Types of treatment intensification for HSPC
7:16 - What can patients and caregivers expect after treatment for HSPC?
10:46 - Questions for patients and caregivers to ask their doctor
15:35 - Advice for patients and caregivers about treatment for HSPC
17:56 - Final thoughts

Supported by an independent educational grant from Astellas and Pfizer, Inc.

For more information, please subscribe to our free digital magazine, UrologyHealth extra.

****
July 6, 2023


Explore Further

Share Your Story

Have a story to share? The Urology Care Foundation invites you to share your experience with a urologic condition and how it has affected you or your family.

Make a Differnece

Your tax-deductible gift will help support the millions of patients who are faced with urologic disease. Together, we care.